Hema Now: Personalised Medicine and Immunotherapy in Multiple Myeloma

In this episode of Hema Now, Kenneth Anderson from the Dana-Farber Cancer Institute, Boston, Massachusetts, USA, shares his expert insights in multiple myeloma research. From key takeaways from the recent American Society of Hematology (ASH) Congress to efforts tackling drug resistance, and the challenges in translating laboratory science into the clinic, this episode is a must-watch.   Timestamps:   00:00 – Introduction  01:10 – Overview of multiple myeloma  04:45 – Kenneth's journey into medicine   07:44 – Myeloma microenvironment   13:40 – Bringing laboratory science to the bedside  16:18 – Exciting myeloma breakthroughs   24:00 – Targeting drug resistance  29:50 – Personalised medicine  34:20 – Importance of early intervention  39:40 – A message to those facing multiple myeloma   42:40 – Three magic wishes for healthcare